IFITM3 and acute myeloid leukemia: Cox proportional hazard and Kaplan-Meier models of AML patients integrated from the TCGA, BeatAML and MDACC cohorts revealed that patients with high IFITM3 (>median) expression had significantly worse overall survival (Fig. 5D; Supplementary Fig. 6A–D).